AB Science S.A.
ABSCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.08 | 0.13 | -0.04 | 0.00 |
| FCF Yield | -6.86% | -6.24% | 2.48% | -16,701,715.94% |
| EV / EBITDA | -29.91 | -29.00 | -41.35 | -2.57 |
| Quality | ||||
| ROIC | -47.60% | -37.52% | -47.54% | -51.28% |
| Gross Margin | 29.32% | 152.54% | 83.39% | 68.58% |
| Cash Conversion Ratio | 0.79 | 0.83 | -0.74 | 4.80 |
| Growth | ||||
| Revenue 3-Year CAGR | -12.80% | -13.49% | -16.62% | -16.16% |
| Free Cash Flow Growth | -47.59% | -188.54% | 141.82% | 19.16% |
| Safety | ||||
| Net Debt / EBITDA | -5.56 | -5.40 | -2.91 | -2.57 |
| Interest Coverage | 0.00 | -2.07 | 0.00 | -10.00 |
| Efficiency | ||||
| Inventory Turnover | 10.11 | -1.46 | 0.24 | 0.49 |
| Cash Conversion Cycle | -2,319.84 | 2,090.24 | -9,852.13 | -3,223.46 |